Probing the activation requirements for naive CD8+ T cells with Drosophila cell transfectants as antigen presenting cells

Immunological Reviews

Volumn 165, Issue , 1998, Pages 249-265

  Cai, Zeling ^a   Brunmark, Anders B ^a   Luxembourg, Alain T ^a,c   Garcia, K Christopher ^b   Degano, Massimo ^b   Teyton, Luc ^b   Wilson, Ian ^b   Peterson, Per A ^a   Sprent, Jonathan ^b   Jackson, Michael R ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD8 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; CRYSTAL STRUCTURE; DROSOPHILA; GENETIC TRANSFECTION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSGENE;

EID: 17344374129     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01243.x     Document Type: Review

References (65)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-296.
2. Janeway CA, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994;76:275-285.
3. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994;76:287-299.
4. Miceli MC, Parnes JR. Role of CD4 and CD8 in T cell activation and differentiation. Adv Immunol. 1993;53:59-122.
5. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993;11:191-212.
6. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell co-stimulation. Annu Rev Immunol 1996;14:233-258.
7. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a co-stimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445-480.
8. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell 1994;76:263-274.
9. Schwartz RH. Co-stimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992;71:1065-1068.
10. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994;15:321-331.
11. Boise LH, et al. CD28 co-stimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity 1995;3:87-98.
12. Schwartz RH. T cell clonal anergy. Curr Opin Immunol 1997;9:351-357.
13. Van Seventer GA, Shimizu Y, Horgan KJ, Shaw S. The LFA-1 ligand ICAM-1 provides an important co-stimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 1990;144:4579-4586.
14. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314.
15. Shimizu Y, van Seventer GA, Horgan KJ, Shaw S. Roles of adhesion molecules in T-cell recognition: fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding, and co-stimulation. Immunol Rev 1990;114:109-143.
16. + T lymphocytes. J Immunol 1993;151:2368-2379.
17. Bachmann MF, et al. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus co-stimulation. Immunity 1997;7:549-557.
18. Hintzen RQ, Lens SMA, Lammers K, Kuiper H, Beckmann MP, van Lier RAW. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J Immunol 1995;154:2612-2623.
19. Liu Y, Jones B, Aruffo A, Sullivan KM, Linsley PS, Janeway CA Jr. Heat-stable antigen is a co-stimulatory molecule for CD4 T cell growth. J Exp Med 1992;175:437-445.
20. Shahinian A, et al. Differential T cell co-stimulatory requirements in CD28-deficient mice. Science 1993;261:609-612.
21. Shier P, et al. Impaired immune responses toward alloantigens and tumor cells but normal thymic selection in mice deficient in the β.2 integrin leukocyte function-associated antigen-1. J Immunol 1996;157:5375-5386.
22. Sha WC, Nelson CA, Newberry RD, Kranz DM, Russell JH, Loh DY. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 1988;335:271-274.
23. + T cells. Proc Natl Acad Sci USA 1996;93:14736-14741.
24. Kranz DM, Sherman DH, Sitkovsky MV, Pasternack MS, Eisen HN. Immunoprecipitation of cell surface structures of cloned cytotoxic T lymphocytes by clone-specific antiserums. Proc Natl Acad Sci USA 1984;81:573-577.
25. Kranz DM, Tonegawa S, Eisen HN. Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1984;81:7922-7926.
26. b mutations that involve peptide binding. Proc Natl Acad Sci USA 1990;87:6186-6190.
27. + cytotoxic T lymphocytes in association with a class I MHC protein. Cell 1992;69:989-998.
28. + T-cell done. Proc Natl Acad Sci USA 1993;90:11272-11276.
29. Cai Z, Sprent J. Resting and activated T cells display different requirements for CD8 molecules. J Exp Med 1994;179:2005-2015.
30. b mutations that involve peptide binding. Proc Natl Acad Sci USA 1990;87:6186-6190.
31. Tallquist MD, Pease LR. Alloreactive 2C T cells recognize a self peptide in the context of the mutant Kbm3 molecule. J Immunol 1995;155:2419-2426.
32. Tallquist MD, Yun TJ, Pease LR. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J Exp Med 1996;184:1017-1026.
33. Tallquist MD, Weaver AJ, Pease LR. Degenerate recognition of alloantigenic peptides on a positive-selecting class I molecule. J Immunol 1998;160:802-809.
34. Garcia KC, et al. αβ T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc Natl Acad Sci USA 1997;94:13838-13843.
35. Corr M, et al. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 1994;265:946-949.
36. + T cells in vitro. J Exp Med 1996;183:2247-2257.
37. Yang Y, et al. Major histocompatibility complex (MHC)-encoded HAM2 is necessary for antigenic peptide loading onto class IMHC molecules. J Biol Chem 1992;267:11669-11672.
38. Jackson MR, Song ES, Yang Y, Peterson PA. Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells. Proc Natl Acad Sci USA 1992; 89:12117-12121.
39. + T cells: implications for tumor immunotherapy. Immunity 1996;4:555-564.
40. Germain RN. T-cell signaling: the importance of receptor clustering. Curr Biol 1997;7: R640-R644.
41. Garcia KC, et al. An αβ T cell receptor structure at 2.5 .ANG. and its orientation in the TCR-MHC complex. Science 1996;274:209-219.
42. Garcia KC, et al. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 1998;279:1166-1172.
43. Ding Y-H, Smith KJ, Garboczi DN, Utz U, Biddison WE, Wiley DC. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/tax peptide complex using different TCR amino acids. Immunity 1998;8:403-411.
44. d peptide complexes. Immunity 1998;8:553-562.
45. Brock R, Wiesmuller K-H, Jung G, Walden P. Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor. Proc Natl Acad Sci USA 1996; 93:13108-13113.
46. Manning TC, et al. Alanine scanning mutagenesis of an αβ T cell receptor: mapping the energy of antigen recognition. Immunity 1998;8:413-425.
47. Valitutti S, Lanzavecchia A. A serial triggering model of TcR activation. The Immunologist 1995;3:122-124.
48. + T cells. J Exp Med 1997;185:641-651.
49. Valitutti S, Mueller S, Cella M, Padovan E, Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995;375:148-150.
50. Viola A, Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science 1996;273:104-106.
51. Valitutti S, Mueller S, Dessing M, Lanzavecchia A. Signal extinction and T cell repolarization in T helper cell-antigen-presenting cell conjugates. Eur J Immunol 1996;26:2012-2016.
52. Salter RD, et al. A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2. Nature 1990;345:41-46.
53. Garcia KC, et al. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 1996;384:571-581.
54. Thome M, Germain V, DiSanto JP, Acuto O. The p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated T cell receptor/CD3/ζ complex. Eur J Immunol 1996;26:2093-2100.
55. Fung-Leung WP, et al. CD8 is needed for positive selection but differentially required for negative selection of T cells during thymic ontogeny. Eur J Immunol 1993;23:212-216.
56. Nourse J, et al. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994;372:570-573.
57. Ledbetter JA, June CH, Martin PJ, Spooner CE, Hansen JA, Meier KE. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to the second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation. J Immunol 1986;136:3945-3952.
58. Springer TA, Dustin ML, Kishimoto TK, Marlin SD. The lymphocyte function associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol 1987;5:223-252.
59. McGuire KL, Iacobelli M. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells. J Immunol 1997;159:1319-1327.
60. Kaga S, Ragg S, Rogers KA, Ochi A. Activation of p21-CDC42/Rac-activated kinases by CD28 signaling: p21-activated kinase (PAK) and MEK kinase 1 (MEKK1) may mediate the interplay between CD3 and CD28 signals. J Immunol 1998;160:4182-1189.
61. Klasen S, Pages F, Peyron J-F, Cantrell DA, Olive D. Two distinct regions of the CD28 intracytoplasmic domain are involved in the tyrosine phosphorylation of Vav and GTPase activating protein-associated p62 protein. Int Immunol 1998;10:481-489.
62. Sykulev Y, Brunmark A, Jackson M, Cohen RJ, Peterson PA, Eisen HN. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity 1994;1:15-22.
63. Sykulev Y, et al. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc Natl Acad Sci USA 1994; 91:11487-11491.
64. Van den Eynde B, Lethe B, van Pel A, De Plaen E, Boon T. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J Exp Med 1991;173:1373-1384.
65. Corr M, Boyd LF, Frankel SR, Kozlowski S, Padlan EA, Margulies DH. Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex. J Exp Med 1992;176:1681-1692.